The Guardian: FDA reverses course and will review Moderna’s mRNA-based flu vaccine

Following backlash after it initially refused to review Moderna’s mRNA influenza vaccine, the US Food and Drug Administration (FDA) will now review the vaccine.

Moderna submitted an application for the FDA to approve the new product in December 2025. Other countries, including Australia, accepted the vaccine for review. The FDA’s initial refusal to review the vaccine sparked concerns about the influence of the current administration.

Read the full article at The Guardian: FDA reverses course and will review Moderna’s mRNA-based flu vaccine.


Updated immunisation reference page: Specialist immunisation services

MVEC’s Specialist immunisation services page was recently updated to include details of the new antenatal vaccination service at Northern Health.

Find more details about the new service at MVEC: Specialist immunisation services.


ABC: Parents fail to return consent forms as Far North Queensland HPV vaccination rate drops

Queensland’s HPV vaccination rates have declined since 2019. Public health experts are concerned about particularly low vaccination rates in some areas, pointing to systemic issues causing students to miss vaccines.

Read the article in full at ABC: Parents fail to return consent forms as Far North Queensland HPV vaccination rate drops.

Read more about human papillomavirus at MVEC: HPV.


Victorian Department of Health: Ongoing measles alert

The health alert for increased travel-related measles cases in Victoria remains open. The health alert includes a list of public exposure sites and details about the current risk of measles. Measles cases have also been reported in other jurisdictions (including NSWQldSA 

 WA).

Read Victoria’s measles alert in full at Increased travel-related measles cases in Victoria. 

Vaccination is the best way to protect yourself and others against measles. Read more about measles disease, transmission, epidemiology and prevention at MVEC:麻疹. 


WHO: Myth-busters: debunking long COVID myths and misconceptions

World Health Organization (WHO) has developed 8 myth-busters and accompanying resources to counter misinformation about long COVID. 

Share campaign materials to help debunk myths and misconceptions. Read more and access materials at WHO: Myth-busters: debunking long COVID myths and misconceptions. 

Read more about COVID-19 disease at MVEC:COVID-19.


Australian CDC: Nipah Virus Infection Situation Update

On 9 February the Australian Centre for Disease Control (CDC) published its latest situation update on Nipah virus infection in West Bengal, India and Rajshahi, Bangladesh. The report includes details about the current situation and its relevance to Australia, and details about Nipah virus epidemiology.

Read the full report here: Australian CDC Situation update: Nipah virus infection in West Bengal, India and Rajshahi, Bangladesh


Benchmarque Group: Upcoming virtual workshops

Benchmarque Group will host 2 virtual workshops on the topic of immunisation catchup. Learn more and register for workshops via the event pages linked below. 

Basic Catchups for Immunisation: 23 April 2026 
Complex Catchups for Immunisation: 30 April 2026

Learn more about immunisation catchups at MVEC: Catch-up immunisation


Spleen Australia webinar: Living Without a Spleen: Translating Guidelines into Everyday Care

澳大利亚脾脏 presents this practical, case-based webinar, designed to support GPs and other healthcare providers to confidently apply current Australian recommendations and integrate Spleen Australia into routine primary care workflows. 

日期: 17 March 2026
时间: 6:00–8:00 pm (AEDT) 

Registration details:
https://us02web.zoom.us/j/88438345169?pwd=T9yEIvM3Ppq0xouzAgMURfJHKHuuTh.1
Meeting ID - 88438345169
Password - 3VZ7QU 


WHO webinar: Real-World Evidence on RSV Vaccines and Monoclonal Antibodies: Effectiveness, Surveillance, and Early Implementation Insights

This upcoming World Health Organization webinar will share early real-world evidence on RSV prevention product effectiveness, genomic surveillance findings on breakthrough infections, and key programmatic lessons from early adopting countries. 

日期: 25 February 2026 
时间: 9:00–10:30 am (CET) (7:00–8:30 pm AEDT) 

Register here

Learn more about RSV disease, transmission, epidemiology and prevention at MVEC: RSV


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。